Application of MRS to mouse models of neurodegenerative illness.
about
Elusive roles for reactive astrocytes in neurodegenerative diseasesCombinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infectionMetabolic changes in the visual cortex of binocular blindness macaque monkeys: a proton magnetic resonance spectroscopy studyA longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 miceR-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease.The interaction between apparent diffusion coefficients and transverse relaxation rates of human brain metabolites and water studied by diffusion-weighted spectroscopy at 7 T.Diffusion-weighted chemical shift imaging of human brain metabolites at 7T.In vivo diffusion MRS investigation of non-water molecules in biological tissues.Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models.Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation.Anti-inflammatory treatment in AD mice protects against neuronal pathology.Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder.Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent N-acetylaspartate.Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.Cortical metabolites as biomarkers in the R6/2 model of Huntington's disease.Effects of Xiaoshuan enteric-coated capsule on neurovascular functions assessed by quantitative multiparametric MRI in a rat model of permanent cerebral ischemiaModeling diffusion of intracellular metabolites in the mouse brain up to very high diffusion-weighting: Diffusion in long fibers (almost) accounts for non-monoexponential attenuation.Cerebral magnetic resonance imaging in quiescent Crohn's disease patients with fatigueEthanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.Brain intracellular metabolites are freely diffusing along cell fibers in grey and white matter, as measured by diffusion-weighted MR spectroscopy in the human brain at 7 T.New paradigm to assess brain cell morphology by diffusion-weighted MR spectroscopy in vivo.Myelin and axon abnormalities in schizophrenia measured with magnetic resonance imaging techniquesAlzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics.Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites.Reproducibility and optimization of in vivo human diffusion-weighted MRS of the corpus callosum at 3 T and 7 T.Treatment effects in a transgenic mouse model of Alzheimer's disease: a magnetic resonance spectroscopy study after passive immunizationAPP transgenic mice: their use and limitations.Imaging and spectroscopic approaches to probe brain energy metabolism dysregulation in neurodegenerative diseases.Axonal and glial microstructural information obtained with diffusion-weighted magnetic resonance spectroscopy at 7T.¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.The effects of aging, housing and ibuprofen treatment on brain neurochemistry in a triple transgene Alzheimer's disease mouse model using magnetic resonance spectroscopy and imaging.Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War Illness in a mouse model of the disease.Metabolic Changes in the Bilateral Visual Cortex of the Monocular Blind Macaque: A Multi-Voxel Proton Magnetic Resonance Spectroscopy Study.Altered brain metabolism after whole body irradiation in mice: a preliminary in vivo 1H MRS study.Brain Metabolite Diffusion from Ultra-Short to Ultra-Long Time Scales: What Do We Learn, Where Should We Go?Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease.Metabolomics as a tool for personalizing medicine: 2012 update.Diverse application of MRI for mouse phenotyping.
P2860
Q26797399-96A408AB-2F7A-4ADD-96C0-33575FF74ACBQ28394163-F88F9818-CB9C-4314-8CB3-705BB504D3BAQ28534833-8B1E479F-8239-4158-BA11-BD82B0C72BADQ30635401-0E88F84A-5423-4A32-9CF8-5D42DE8647ADQ30684317-4ACBFD12-3447-41BD-843C-BFF7365B9795Q30794733-A8E5F3C3-3B3D-45E4-8436-C772CE6085ACQ30834531-226AF9CE-132F-45AB-BDEB-16A6548A0623Q31039035-B59E2CA9-EEBF-421A-BDF2-A34FD11FE9F9Q33558132-5F8C2A9B-E733-4133-B04E-9D5636F3A2C5Q33757934-DB6D473D-216C-4CF7-8A42-E859ADBC7F51Q33828970-7891962E-2D96-4F2C-920E-A2777E3EDCBBQ33857211-83AFD0C9-7DF3-4775-AFDF-936A4289275EQ33869743-25AD97CE-0612-45B4-BE56-CC79E4B7E56EQ34372998-EC90E4A0-7447-4FA5-BE06-FDE82C7CC899Q35800506-372832CA-50E1-470C-8A42-DA4AEC767632Q36071562-8222223C-7DC9-4E97-AACA-89CA58BDBFDAQ36194245-45A721AF-0912-4035-9AAB-48CE2849842FQ36293312-A93ECFE0-D500-4866-ACCB-9BF1B6E08491Q36493462-07D71801-81CE-4AEE-9A21-2AD33C9B5743Q36841539-BF63ECE4-7BF5-44FB-9187-992377C976D4Q36931588-F3FF11A4-1F11-430B-A489-CB415B681ACAQ37021697-B8CF1A55-8385-433E-8059-46F2A0360DF4Q37038678-2A2691FF-18EA-4CBD-95CE-8402D6449499Q37191378-CD204E2F-B33B-4446-8EFC-850071E1124AQ37220640-CB3D24D6-57D5-4184-B8FC-BF2E1F245334Q37370499-0D7B9828-B004-4C38-871F-EB985198B25CQ37592339-3811F1D7-6FB7-49A4-9199-C8214457288BQ37820330-65F3F210-9AC5-453F-8D9E-AF1112AF06FFQ38918493-324AB386-7611-4146-B2C8-DD60799E7727Q41215893-5E39F96C-373A-4B6F-A51E-D0D213D276CCQ41288398-C145B309-2C91-4896-8CE5-A9EE2137904FQ43077710-9A516C4D-8564-4084-82D6-9CE63B8D8565Q47249544-D4A5260D-3D40-48C4-9A43-C8C49F5BE28CQ48184029-82DE8616-49C4-48F1-A7DB-889C803EE511Q48358948-2692E864-C2F8-448C-BF38-E0DBB1F8D935Q49168822-9953602A-4ECB-46F1-92EF-A3A91095F89DQ50907255-A767F5D8-62B1-430A-8927-0DBD6560A7D6Q52365595-29D1E155-1DC9-41DA-BBB8-21D44F419CE4Q54257582-A86DD158-9DB9-4791-88C8-B7E189D3D180Q55029173-06515CAE-64C5-404D-A540-52CDD3DE15AA
P2860
Application of MRS to mouse models of neurodegenerative illness.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Application of MRS to mouse models of neurodegenerative illness.
@ast
Application of MRS to mouse models of neurodegenerative illness.
@en
type
label
Application of MRS to mouse models of neurodegenerative illness.
@ast
Application of MRS to mouse models of neurodegenerative illness.
@en
prefLabel
Application of MRS to mouse models of neurodegenerative illness.
@ast
Application of MRS to mouse models of neurodegenerative illness.
@en
P2093
P356
P1433
P1476
Application of MRS to mouse models of neurodegenerative illness.
@en
P2093
Alpaslan Dedeoglu
Bruce G Jenkins
Ji-Kyung Choi
P304
P356
10.1002/NBM.1145
P577
2007-05-01T00:00:00Z